Department of Medicine
Faculty Profiles by Division

Department of Medicine

Faculty Profiles

[Return To Index page]
photo Priya Rastogi, MD


Associate Professor of Medicine

Member, Magee/UPCI Breast Program


Phone: 412-641-3494

Office: Magee-Womens Hospital
300 Halket Street, Room 3524
Pittsburgh, PA 15213
Phone: 412-641-3494
Fax: 412-641-6461
Administrative Assistant:
Debbie Thomas
Address: 300 Halket Street
Magee Womens Hospital, Room 3524
Pittsburgh, PA 15213
Phone: 412-641-6500
Fax: 412-641-6461
Education and Training
Bachelor of Arts in Chemistry, Miami University, Oxford, OH, 1993
Doctor of Medicine, Wright State University, Dayton, OH, 1997
Internal Medicine Residency, Saint Joseph Hospital, Denver, CO, 2000
Hematology/Oncology Fellowship, University of Pittsburgh School of Medicine, 2003
Research Interest
I am involved with the development and implementation of phase II and phase III clinical trials and serve as the protocol officer for phase II and phase III adjuvant and neoadjuvant breast cancer clinical trials. I am a published author in several medical journals including: Journal of Clinical Oncology, Clinical Breast Cancer, New England Journal of Medicine, Oncology, Oncology Nurse Forum, Onkologie, Menopause, and Breast Cancer Research Treatment
Clinical Interest
I am an Associate Professor of Medicine at the University of Pittsburgh, School of Medicine. I also serve as Senior Associate Medical Director and Vice Chair for Medical Affairs with the NSABP Foundation. I am a Board Certified Medical Oncologist who specializes in breast cancer and sees patients at the Women’s Cancer Center in Magee-Women’s Hospital of UPMC.
For my complete bibliography, Click Here.
Selected Publications:
Smith, J.W.2nd, Buyse, M.E., Rastogi, P., Geyer, C.E. Jr, Jacobs, S.A., Patocskai, E.J., Robidoux, A., Conlin, A.K., Ansari, B., Keogh, G.P., Stella, P.J., Gross, H.M., Lord, R.S., Polikoff, J.A., Mauquoi, C., Mamounas, E.P., Swain, S.M., Wolmark, N. Epirubicin with Cyclophosphamide followed by Docetaxel with trastuzumab and Bevacizumab as neoadjuvant therapy for HER2-Positive locally advanced Breast Cancer or as adjuvant therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5. Clinical Breast Cancer. 2016.
Gavin, P.G., Song, N., Kim, S.R., Lipchik, C., Johnson, N.L., Bandos, H., Finnigan, M., Rastogi, P., Fehrenbacher, L., Mamounas, E.P., Swain, S.M., Wickerham, D.L., Geyer, C.E., Jr., Jeong, J.H., Costantino, J.P., Wolmark, N., Paik, S., Pogue-Geile, K.L. Association of Polymorphisms in FCGR2A and FCGR3A with degree of Trastuzumab benefit in the Adjuvant Treatment of ERBB2/HER2Positive Breast Cancer: Analysis of the NSABP B-31 Trial. Journal American Medical Association Oncology. 2017.
Bear, H.D., Tang, G., Rastogi, P., Geyer, C.E. Jr, Zoon, J.A., Kidwell, K.M., Robidoux, A., Baez-Diaz, L., Brufsky, A.M., Mehta, R.S., Fehrenbacher, L., Young, J.A>, Senecal, F.M., Gaur, R., Margolese, R.G., Adams, P.T., Gross, H.M., Costantinao, J.P., Paik, S., Swain, S.M. The effect on Surgical Complications of Bevacizumab added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40. Annals of Surgical Oncology. 2017.
Rastogi, P., Wickerham, D.L., Geyer, C.E., Jr., Mamounas, E.P., Julian, T.B., Wolmark, N. Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP). Clinical Oncology. 2017.
Koleck, T.A., Bender, C.M., Clark, B.Z., Ryan, C.M., Gotakar, P., Brufsky, A.M., McAuliffe, P.F., Rastogi, P., Sereika, S.M., Conley, Y.P. An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors. Breast Cancer. 2017.
Lohmann, A.E., Liebman, M.F., Brien, W., Parulekar, W.R., Gelmon, K.A., Shepherd, L.E., Ligibel, J.A., Hershman, D.L., Rastogi, P., Mayer, I.A., Hobday, T.J., Lemieux J., Thompsson, A.M., Pritchard, K.L., Whelan, T.J., Mukherjee, S.D., Chalchal, H.I., Bernstein, V., Stambolic, V., Chen, B.E. Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32. Breast Cancer Research Treatment. 2017.
Ganz, P.A., Romond, E.H., Cecchini, R.S., Rastogi, P., Geyer, C.E., Jr, Swain, S.M., Jeong, J.H., Fehrenbacher, L., Gross, H.M., Brufsky, A.M., Flynn, P.J., Wahl, T.A., Seay, T.E., Wade, J.L.III, Biggs, D.D, Atkins, J.N., Polikoff, J., Zapas, J.L., Mamounas, E.P., Wolmark, N. Long term follow up of cardiac function and quality of life for patients in NSABP Protocol B-31/NRG Oncology: a randomized trial comparing the safety and efficacy of Doxorubicin and Cyclophosphamide (AS) followed by Paclitaxel with AC followed by Paclitaxel and Trastuzumab in patients with node positive breast cancer with tumors over expressing Human Epidermal Growth factor receptor. Journal of Clinical Oncology. 2017.
Wapnir, I.L., Prie, K.N., Anderson, S.J., Robidoux, A., Martin, M., Nortier, J.W.R., Paterson, A.H.G., Rimawi, M.IF., Lang, I., Baena-Canada, J.M., Thurlimann, B., Mamounas, E.P., Geyer, C.E., Jr., Gelber, S., Rastogi, P., Regan, M.M., Wolmark, N., Aebi, S., et. all. Efficacy of Chemotherapy for ER-Negative and ER- Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CLALOR Trial. Journal of Clinical Oncology. 2018.
Lobil, S., O'Shaughnessy, J., Untch, M., Sikov, W.M., Rugo, H.S., McKee, M.D., Huober, J., Gloshan, M., von Minckwitz, G., maag, D., Sullivan, D., Wolmark, N., McIntyre, K., Ponce Lorenzo, J.J., Metzger Filho, O., Rastogi, P., Symmans, W.F., Liu, X., Geyer, C.E., Jr. Addition of the PARP inhibitor veliparib plus carboplatin alone to standard neoadjuvant chemotherapy in triple negative breast cancer (BrighTNess): a randomized, phase 3 trial. Lancet Oncology. 2018.
Schroeder, M.C., Rastogi, P., Geyer, C.E., Jr., Miller, L.D., Thomas, A. Early and locally advanced metastatic breast cancer: Presentation and Survival by receptor status in surveillance, epidemiology and end results. Oncologist. 2018.
Notable Achievements
Malcolm E Switzer MD Award, 1992
Harvy Clayton Brill and Stalzer Scholarships, 1992
Golden Key Nation Honor Society, Vice President, 1992-1993
Miami Medicine Honorary Program, 1992-1993
Miami Medicine Honarary Program, Co-President, 1992-1993
Gamma Theta Pi Chemistry Honarary Society, 1992-1993
Sandoz Award, Recognition for outstanding student in Psychiatry, 1996
Dr. Anni Yee Johnson Memorial Award, Presented to the resident who exemplified qualities of thoroughness, motivation, caring, campassion, efficiency and professionalism, 2000
Resident of the Year Award, 2000
Honored Member Strathmore's Who's who, 2004-2005